ASCEND
BY NTHRYS

NTHRYSPhD AssistanceNeuroepidemiology

Neuroepidemiology

Field
Category

Neuroepidemiology

Select a category to explore research frontiers

Neuroepidemiology200 categories·70 research gap frontiers·30 UIRGs·access £41
UIRG Unique Individual Research GapFrontier Research Gap Frontier, groups 3+ UIRGsChip badge 4 UIRGs in that frontier🔓 One fee unlocks every UIRG under a frontier🧬 Illustrated: graphical abstract published
PathFieldCategoryFrontierUIRGPhD assistance services
Neuroinflammatory Biomarkers in Population Epidemiology
10 frontiers
30
UIRGS
Investigation of systemic and central nervous system inflammatory markers as predictive indicators for neurodegenerative disease risk in large population cohorts.
RESEARCH GAP FRONTIERS
Systemic Inflammation Signatures in Preclinical Neurodegeneration3Glial Activation Biomarkers Across Population Lifecourses3Neuroinflammatory Trajectories in Cognitively Normal Aging3+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Genetic Susceptibility and Environmental Interaction Studies
10 frontiers
10+
UIRGS
Analysis of gene-environment interactions in neurological disease etiology using advanced genotyping and exposure assessment methodologies.
RESEARCH GAP FRONTIERS
Gene-Environment Convergence in Neurodegenerative ThresholdsPolygenic Risk and Environmental Stressors in EpileptogenesisExposomic Mapping of Genetic Vulnerability in Neurological Phenotypes+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Neurodegeneration Risk Stratification Using Machine Learning
10 frontiers
10+
UIRGS
Development and validation of artificial intelligence models to predict neurodegenerative disease progression in at-risk populations.
RESEARCH GAP FRONTIERS
Polygenic Risk and Neurodegeneration Phenotype HeterogeneityTemporal Dynamics of Biomarker Trajectories in Preclinical NeurodegenerationMulti-Modal Integration for Early Neurological Decline Detection+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Traumatic Brain Injury Population Outcomes Registry
10 frontiers
10+
UIRGS
Large-scale epidemiological tracking of long-term neurological sequelae and disability trajectories following traumatic brain injury in community populations.
RESEARCH GAP FRONTIERS
Post-Traumatic Neuroinflammation and Long-Term Cognitive TrajectoriesGenetic Vulnerability and Differential Recovery Phenotypes After TBIChronic Traumatic Encephalopathy Biomarkers in Population Cohorts+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Dementia Incidence Trends Across Geographic Regions
10 frontiers
10+
UIRGS
Comparative analysis of age-adjusted dementia incidence rates and temporal trends across diverse geographic populations and healthcare systems.
RESEARCH GAP FRONTIERS
Geographic Dementia Epidemiology and Migration PatternsLatitude-Dependent Neuropathological Burden in DementiaUrban-Rural Cognitive Decline Divergence and Risk Stratification+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Sleep Disorders and Cognitive Decline Population Studies
10 frontiers
10+
UIRGS
Longitudinal investigation of sleep architecture abnormalities as independent risk factors for mild cognitive impairment and dementia in population-based cohorts.
RESEARCH GAP FRONTIERS
Sleep Fragmentation and Amyloid Accumulation in Population CohortsCircadian Desynchrony as a Cognitive Decline AcceleratorREM Sleep Loss and Tau Pathology in Aging Populations+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Migraine Epidemiology and Stroke Risk Associations
10 frontiers
10+
UIRGS
Examination of migraine phenotypes and their associations with cardiovascular and cerebrovascular disease incidence in large prospective cohorts.
RESEARCH GAP FRONTIERS
Migraine Aura as a Cerebrovascular Vulnerability MarkerEstrogen Fluctuation and Ischemic Stroke Susceptibility in MigraineursCortical Spreading Depression and Arterial Dysfunction Networks+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Neurological Outcomes in Viral Pandemic Populations
Real-time epidemiological surveillance of acute and chronic neurological complications following viral infections in geographically distributed populations.
Explore frontiers →
Occupational Neurotoxic Exposure and Disease Burden
Assessment of long-term neurological health outcomes in workers with chronic occupational exposure to neurotoxic substances using epidemiological cohort designs.
Explore frontiers →
Neuropsychiatric Symptom Burden in Community Populations
Population-level assessment of depression, anxiety, and cognitive symptoms as emerging risk factors and prodromal indicators in neurodegenerative disease progression.
Explore frontiers →
Apolipoprotein E Polymorphism and Dementia Phenotypes
Investigation of how APOE genotypes modify neurodegenerative disease manifestation, severity, and progression trajectories across diverse populations.
Explore frontiers →
Urban Air Pollution and Neurological Disease Risk
Assessment of fine particulate matter and air pollutant exposures as environmental risk factors for neuroinflammation and cognitive decline in urban populations.
Explore frontiers →
Epilepsy Epidemiology in Low-Income Settings
Characterization of epilepsy incidence, prevalence, treatment gaps, and mortality outcomes in resource-limited populations with different healthcare access.
Explore frontiers →
Neurological Disability Burden Measurement Methods
Development and validation of standardized neurological disability assessment tools for population-based surveys across different cultural and healthcare contexts.
Explore frontiers →
Cardiovascular Risk Factors and Brain Health
Longitudinal analysis of hypertension, diabetes, and dyslipidemia trajectories as modifiable risk factors for cognitive decline and stroke in aging populations.
Explore frontiers →
Parkinson''s Disease Prodromal Biomarker Identification
Population-based detection of premotor symptoms and objective biomarkers that identify high-risk individuals for future Parkinson''s disease development.
Explore frontiers →
Multiple Sclerosis Clustering and Environmental Triggers
Spatial epidemiological analysis of multiple sclerosis incidence clusters and investigation of temporal environmental exposure associations in susceptible populations.
Explore frontiers →
Cognitive Reserve and Dementia Resilience Mechanisms
Examination of educational achievement, occupational complexity, and cognitive engagement as protective factors modulating dementia risk in aging populations.
Explore frontiers →
Neurological Sequelae Following Childhood Infections
Long-term follow-up studies tracking neurodevelopmental and neurological outcomes in children with history of meningitis, encephalitis, or other CNS infections.
Explore frontiers →
Hearing Loss and Cognitive Decline Association Studies
Investigation of age-related hearing impairment as an independent risk factor for cognitive dysfunction and dementia in population-based prospective cohorts.
Explore frontiers →
Social Isolation and Neurodegenerative Disease Risk
Analysis of social engagement patterns and loneliness as psychosocial risk factors influencing neuroinflammation and cognitive decline trajectories in older adults.
Explore frontiers →
Amyloid and Tau Biomarker Epidemiology in Asymptomatic
Population-based prevalence studies of brain amyloid and tau pathology in cognitively normal individuals using neuroimaging and cerebrospinal fluid biomarkers.
Explore frontiers →
Metabolic Syndrome and Alzheimer''s Disease Pathogenesis
Longitudinal investigation of obesity, insulin resistance, and metabolic dysfunction components as drivers of Alzheimer''s disease neuropathology in middle-aged populations.
Explore frontiers →
Stroke Incidence Prediction and Prevention Strategies
Development of validated risk prediction models and evaluation of targeted intervention effectiveness for reducing stroke incidence in high-risk population subgroups.
Explore frontiers →
Neurological Impact Assessment in Refugee Populations
Characterization of neurological disease burden, mental health comorbidities, and access barriers in displaced and refugee populations with unique exposure histories.
Explore frontiers →
Frailty Phenotype and Neurological Disease Progression
Investigation of physical frailty as a predictor and consequence of progressive neurological disease in community-dwelling older adult populations.
Explore frontiers →
Pesticide Exposure and Parkinson''s Disease Risk Nexus
Meta-analysis and pooled epidemiological assessment of agricultural pesticide exposures as environmental risk factors for Parkinson''s disease development.
Explore frontiers →
Focal Seizure Epidemiology and Drug Resistance Patterns
Population-based characterization of focal epilepsy phenotypes, treatment outcomes, and predictors of pharmacoresistance across diverse clinical populations.
Explore frontiers →
Neuroimaging Biomarkers in Early Cognitive Aging
Structural and functional brain imaging epidemiology identifying preclinical changes predicting cognitive decline onset in cognitively normal aging populations.
Explore frontiers →
Vascular Cognitive Impairment Phenotype Heterogeneity
Longitudinal characterization of distinct vascular cognitive impairment subtypes and their associations with specific cerebrovascular lesion patterns and outcomes.
Explore frontiers →
Medication Adverse Events and Neurological Safety Signals
Pharmacoepidemiology surveillance of neurological adverse effects from medications and identification of drug-induced neurotoxicity patterns in large population databases.
Explore frontiers →
Linguistic and Cultural Barriers in Neurological Assessment
Development of culturally appropriate and linguistically valid neurological screening and diagnostic instruments for diverse immigrant and minority populations.
Explore frontiers →
Alcohol Consumption Patterns and Brain Atrophy Trajectory
Longitudinal neuroimaging epidemiology examining dose-response relationships between alcohol consumption patterns and progressive structural brain changes in community samples.
Explore frontiers →
Late-Life Depression as Dementia Prodrome Indicator
Investigation of late-onset depression as a potential early clinical manifestation and risk marker for subsequent neurodegenerative disease development in aging populations.
Explore frontiers →
Gut Microbiome Composition and Neurological Disease
Cross-sectional and longitudinal analysis of microbial dysbiosis patterns as novel environmental and biological risk factors for neuroinflammatory and neurodegenerative conditions.
Explore frontiers →
Spinal Cord Injury Epidemiology and Neurological Recovery
Population-based tracking of spinal cord injury incidence, complications, neurological recovery patterns, and long-term disability outcomes across diverse healthcare systems.
Explore frontiers →
Neuropathic Pain Prevalence in Chronic Disease Populations
Epidemiological assessment of neuropathic pain burden among patients with diabetes, cancer, and other chronic conditions and impact on quality of life.
Explore frontiers →
Seasonal Variation in Neurological Disease Exacerbation
Analysis of temporal and seasonal patterns in neurological disease onset, symptom exacerbation, and relapse occurrence in population registries and healthcare databases.
Explore frontiers →
Apoplexy Risk in Atrial Fibrillation Population Cohorts
Assessment of stroke risk stratification and efficacy of anticoagulation strategies in atrial fibrillation populations using prospective cohort study designs.
Explore frontiers →
Cannabis Use and Neurological Safety Long-Term Outcomes
Prospective epidemiological investigation of cannabis exposure effects on brain structure, cognitive function, and neurological disease risk across lifespan trajectories.
Explore frontiers →
Neurological Manifestations in Systemic Autoimmune Diseases
Characterization of central and peripheral nervous system involvement prevalence and outcomes in populations with systemic lupus erythematosus and related conditions.
Explore frontiers →
Medication Polypharmacy and Cognitive Decline Risk
Assessment of the cumulative and interactive effects of multiple medications on cognitive aging and dementia risk in older adult population cohorts.
Explore frontiers →
Neuromuscular Disease Burden in Resource-Limited Countries
Epidemiological characterization of inherited and acquired neuromuscular disease prevalence, diagnostic access, and disability impact in low-income populations.
Explore frontiers →
Postoperative Cognitive Dysfunction Population Epidemiology
Large-scale assessment of postoperative delirium and long-term cognitive outcomes following major surgery in aging and vulnerable populations.
Explore frontiers →
Concussion Cumulative Effects on Neurodegenerative Risk
Longitudinal investigation of repeated concussion and subconcussive impacts as risk factors for chronic traumatic encephalopathy and later-life neurodegeneration.
Explore frontiers →
Vitamin Deficiency and Neurological Disease Prevention Studies
Population-based randomized controlled trials of B vitamins and micronutrient supplementation for prevention of cognitive decline and neurological disease.
Explore frontiers →
Occupational Repetitive Strain and Neurological Morbidity
Assessment of occupational repetitive motion exposures and ergonomic factors associated with carpal tunnel syndrome and cumulative peripheral nerve disease.
Explore frontiers →
Chronic Pain Phenotypes and Neuroinflammatory Pathways
Investigation of distinct chronic pain syndrome phenotypes and their neurobiological correlates with central and peripheral sensitization markers.
Explore frontiers →
Nursing Home Neurological Outcomes and Quality Measures
Evaluation of institutional quality measures, care processes, and outcomes for neurological disease management in long-term residential care facilities.
Explore frontiers →
Circadian Rhythm Disruption and Neurodegeneration Risk
Examination of sleep-wake cycle dysregulation and circadian misalignment as modifiable risk factors for cognitive decline and neuroinflammation in aging populations.
Explore frontiers →
Long COVID Neurological Sequelae Population Tracking
Longitudinal epidemiological investigation of persistent neurological complications following SARS-CoV-2 infection across diverse demographic populations.
Explore frontiers →
Environmental Lead Exposure and Subclinical Neurodegeneration
Population-based assessment of cumulative lead exposure effects on neuroimaging markers and cognitive trajectory in aging cohorts.
Explore frontiers →
Prion Disease Surveillance and Molecular Epidemiology
Systematic monitoring and genetic characterization of prion disease incidence and transmission patterns across geographic regions.
Explore frontiers →
Prenatal Maternal Infection and Neurodevelopmental Disorder Risk
Epidemiological cohort analysis examining in utero infectious exposures as risk factors for autism spectrum and developmental disorders.
Explore frontiers →
Neurological Disease Surveillance in Climate-Displaced Populations
Investigation of neurological health outcomes and disease prevalence among populations experiencing climate-related displacement and migration.
Explore frontiers →
Amyloidosis Neurological Manifestation Phenotyping and Epidemiology
Characterization of neurological phenotypes and disease burden in hereditary and acquired systemic amyloidosis populations.
Explore frontiers →
Cannabis Cannabinoid Dosing and Neurological Adverse Event Monitoring
Population pharmacoepidemiology study examining dose-response relationships between cannabinoid consumption and neurological safety outcomes.
Explore frontiers →
Artificial Intelligence Algorithm Bias in Neuroimaging Epidemiology
Assessment of demographic and ethnic disparities in machine learning model performance for neurological disease detection across populations.
Explore frontiers →
Metabolic Endotoxemia and Blood-Brain Barrier Integrity Studies
Investigation of lipopolysaccharide-derived endotoxemia as a driver of neuroinflammation and cognitive decline in community cohorts.
Explore frontiers →
Neurological Disease Clustering in Environmental Justice Communities
Geospatial epidemiological analysis of neurological disease aggregation in disproportionately exposed low-income neighborhoods.
Explore frontiers →
Structural Brain Asymmetry and Neurodevelopmental Disorder Phenotypes
Population neuroimaging study characterizing hemispheric structural differences and their association with neurodevelopmental condition severity.
Explore frontiers →
Infectious Priming and Secondary Neurodegeneration Acceleration Models
Investigation of how repeated or chronic infections accelerate underlying neurodegenerative disease progression in susceptible populations.
Explore frontiers →
Neurological Outcome Disparities in Racial and Ethnic Minorities
Systematic analysis of structural and social factors contributing to differential neurological disease burden and outcomes across racial groups.
Explore frontiers →
Immune Senescence and Age-Related Neurological Vulnerability
Population immunological and epidemiological study of immunosenescence-related changes predicting late-life neurological disease susceptibility.
Explore frontiers →
Wearable Device Neurological Monitoring and Digital Epidemiology
Real-world application of wearable sensor data for continuous population-level detection and tracking of neurological symptoms and disease progression.
Explore frontiers →
Mitochondrial DNA Variants and Neurological Disease Burden Distribution
Population genetics study examining maternal inheritance patterns of mitochondrial mutations and neurological phenotype expression across families.
Explore frontiers →
Neurological Teratogenicity of Novel Pharmaceutical Agents Population Study
Pharmacoepidemiological surveillance of neurodevelopmental outcomes in offspring exposed to recently approved therapeutic medications in utero.
Explore frontiers →
Speech and Language Disorder Epidemiology and Genetic Architecture
Population-based investigation of speech and language impairment prevalence, genetic contributions, and sociodemographic disparities in diverse cohorts.
Explore frontiers →
Urban Green Space Exposure and Neurological Disease Risk Modulation
Environmental epidemiology examining protective effects of urban greenspace access on neurological health outcomes and cognitive aging.
Explore frontiers →
Lyme Disease Neurological Sequelae Long-Term Epidemiologic Outcomes
Longitudinal population study characterizing persistent neurological complications following Lyme borreliosis infection and associated disability.
Explore frontiers →
Neonatal Neurological Screening and Early Intervention Effectiveness Assessment
Evaluation of population-level neurological screening programs and their impact on developmental outcomes in high-risk birth cohorts.
Explore frontiers →
Occupational Noise Exposure and Central Auditory Processing Disorder
Epidemiological investigation of chronic occupational noise-related neurological damage to central auditory processing systems.
Explore frontiers →
Immune Checkpoint Inhibitor Neurotoxicity Population Surveillance Registry
Systematic monitoring and characterization of immunotherapy-related neurological adverse events across cancer treatment populations.
Explore frontiers →
Gut-Blood-Brain Barrier Permeability and Neurological Disease Phenotypes
Investigation of intestinal barrier dysfunction and increased paracellular permeability as pathways to neuroinflammation in population cohorts.
Explore frontiers →
Neurological Disease Mortality Excess in Carceral Populations
Epidemiological study documenting neurological disease mortality disparities and health inequities in incarcerated populations.
Explore frontiers →
Perfluoroalkyl Substance Exposure and Neurological Development Outcomes
Population toxicoepidemiology examining PFAS bioaccumulation effects on childhood neurological development and cognitive outcomes.
Explore frontiers →
Neurovascular Coupling Dysfunction and Cognitive Aging Mechanisms
Investigation of impaired cerebrovascular reactivity as an underlying mechanism for accelerated cognitive decline in aging populations.
Explore frontiers →
Transgender Population Neurological Health Outcome Disparities Study
Examination of neurological disease prevalence, healthcare access barriers, and health outcomes in transgender and gender-diverse populations.
Explore frontiers →
Neurological Comorbidity Networks and Complex Disease Phenotyping
Systems epidemiology approach identifying comorbidity clusters and network patterns in neurological disease co-occurrence across populations.
Explore frontiers →
Intrauterine Growth Restriction and Adult Neurological Disease Vulnerability
Life-course epidemiology examining fetal growth restriction as a developmental programming factor for late-life neurological disease susceptibility.
Explore frontiers →
Neurological Disease Incidence Prediction Using Smartphone Keystroke Dynamics
Digital phenotyping study using smartphone behavioral metrics to predict subclinical neurological disease onset in longitudinal cohorts.
Explore frontiers →
Traumatic Brain Injury Severity Classification and Outcome Heterogeneity
Population-based examination of traditional versus novel TBI severity measures and their predictive validity for long-term outcomes.
Explore frontiers →
Pesticide Metabolite Bioaccumulation and Neurological Disease Trajectory
Longitudinal biomonitoring study tracking organophosphate and pyrethroid pesticide metabolites and neurological symptom progression in agricultural workers.
Explore frontiers →
Neurolymphatic System Dysfunction and Neuroinflammatory Disease Burden
Investigation of glymphatic system impairment as a mechanism underlying neuroinflammation and neurodegenerative disease pathogenesis.
Explore frontiers →
Telomere Shortening and Accelerated Neurological Aging Phenotypes
Population study linking leukocyte telomere length to markers of accelerated brain aging and neurological disease risk.
Explore frontiers →
Structural Racism and Neurological Health Outcome Inequities
Critical epidemiological analysis of how systemic racism and discrimination structures shape neurological health disparities across communities.
Explore frontiers →
Zoonotic Viral Spillover and Emerging Neurological Disease Pandemics
Surveillance and molecular epidemiology of neurotropic zoonotic pathogens and pandemic potential for neurological disease emergence.
Explore frontiers →
Neurological Complication Rates Following Therapeutic Ionizing Radiation Exposure
Population assessment of radiation-induced neurological late-effects including secondary malignancies and neurotoxicity in cancer survivor cohorts.
Explore frontiers →
Maternal Neuropsychiatric Illness and Offspring Neurological Phenotype Outcomes
Intergenerational epidemiological study examining maternal psychiatric disease as risk factor for offspring neurodevelopmental and neurological disorders.
Explore frontiers →
Neurological Disease Incidence Variation by Socioeconomic Mobility Status
Investigation of how lifetime socioeconomic trajectories and economic mobility patterns affect neurological disease incidence in longitudinal cohorts.
Explore frontiers →
Hepatic Encephalopathy Population Epidemiology and Reversibility Predictors
Population study characterizing hepatic encephalopathy incidence, severity phenotypes, and factors predicting reversibility in liver disease populations.
Explore frontiers →
Neurological Disease Onset Clustering and Social Network Transmission Patterns
Network epidemiology examining whether neurological disease onsets cluster temporally or geographically within social networks suggesting transmissible mechanisms.
Explore frontiers →
Brain Derived Neurotrophic Factor Polymorphism and Resilience Mechanisms
Population genetics study investigating BDNF variants as modifiers of neurological disease vulnerability and neuroprotective resilience capacity.
Explore frontiers →
Microplastic Accumulation and Neurological Toxicity Population Exposure Assessment
Environmental toxicoepidemiology examining microplastic ingestion pathways and potential neurological health effects across consumer populations.
Explore frontiers →
Religious and Spiritual Practice Effects on Neurological Disease Prevention and Outcomes
Population epidemiological investigation of psychospiritual factors as protective or risk modifiers for neurological disease incidence and progression.
Explore frontiers →
Neurological Disease Phenotype Variation in Consanguineous Population Clusters
Genetic epidemiology study documenting phenotypic heterogeneity and novel disease manifestations in rare autosomal recessive neurological conditions.
Explore frontiers →
Occupational Electromagnetic Field Exposure and Neurodegenerative Disease Risk
Epidemiological assessment of chronic occupational electromagnetic field exposure as a potential risk factor for neurodegeneration in high-exposure workers.
Explore frontiers →
Neurological Complication Risk Stratification in Diabetes Populations Using Biomarkers
Development and validation of multi-biomarker algorithms for predicting diabetic neuropathy and other neurological complications in diabetes cohorts.
Explore frontiers →
Language Processing Deficits and Dementia Early Detection in Multilingual Populations
Investigation of linguistic biomarkers and language processing changes as early indicators of dementia across multilingual and bilingual populations.
Explore frontiers →
Systemic Inflammation Trajectory and Cognitive Decline Longitudinal Association
Analysis of dynamic inflammatory marker trajectories and their temporal association with onset and progression of cognitive impairment in aging cohorts.
Explore frontiers →
Neurological Outcomes Following Long COVID Infection
Epidemiological characterization of persistent neurological symptoms and cognitive dysfunction in post-acute sequelae of SARS-CoV-2 infection populations.
Explore frontiers →
Hypertension Management and Cognitive Aging Trajectories
Longitudinal population studies examining optimal blood pressure control timing and intensity effects on dementia incidence and cognitive reserve preservation.
Explore frontiers →
Environmental Heavy Metal Neurotoxicity in Pediatric Populations
Assessment of lead, mercury, and cadmium exposure effects on neurodevelopmental outcomes and lifelong neurological disease susceptibility in children.
Explore frontiers →
Atrial Fibrillation Screening and Cryptogenic Stroke Prevention
Population epidemiology of undetected paroxysmal atrial fibrillation prevalence and optimal screening strategies for primary prevention of ischemic stroke.
Explore frontiers →
Amyloid Positron Emission Tomography Screening Programs
Large-scale community-based neuroimaging screening initiatives evaluating asymptomatic amyloid positivity prevalence and cognitive progression risk in aging populations.
Explore frontiers →
Post-Stroke Neuropsychiatric Comorbidity Epidemiology
Population-level characterization of depression, anxiety, and cognitive impairment prevalence and risk factors following acute cerebrovascular events.
Explore frontiers →
Multiple Sclerosis Disease-Modifying Therapy Equity Access
Epidemiological surveillance of geographic and socioeconomic disparities in multiple sclerosis diagnosis timing and disease-modifying treatment availability.
Explore frontiers →
Charcot-Marie-Tooth Disease Phenotype-Genotype Epidemiology
Systematic characterization of genotype-phenotype correlations and disease progression heterogeneity across inherited peripheral neuropathy subtypes in populations.
Explore frontiers →
Traumatic Brain Injury Recovery Biomarker Trajectories
Longitudinal assessment of serum and cerebrospinal fluid biomarker dynamics predicting functional outcomes and post-traumatic neurodegeneration risk.
Explore frontiers →
Work-Related Repetitive Motion Focal Dystonia Incidence
Occupational epidemiology of task-specific dystonia development in musicians, athletes, and manual workers with biomechanical exposure characterization.
Explore frontiers →
Anticoagulation-Associated Intracranial Hemorrhage Prediction
Development and validation of population-based risk stratification models for major bleeding complications in anticoagulated neurological populations.
Explore frontiers →
Amnestic Mild Cognitive Impairment Subtypes and Trajectories
Nosological characterization of amnestic mild cognitive impairment phenotypes and differential progression rates to Alzheimer''s disease dementia.
Explore frontiers →
Diabetic Neuropathy Incidence and Prevention Interventions
Population-based studies of peripheral and autonomic neuropathy development rates in type 1 and type 2 diabetes with preventive strategy evaluation.
Explore frontiers →
Perinatal Hypoxic-Ischemic Encephalopathy Long-Term Sequelae
Longitudinal follow-up of cerebral palsy, intellectual disability, and seizure disorder development in birth cohorts with perinatal hypoxia exposure.
Explore frontiers →
Polygenic Risk Score Development for Neurological Disease
Derivation and cross-population validation of polygenic risk scores for Alzheimer''s disease, Parkinson''s disease, and stroke susceptibility prediction.
Explore frontiers →
Retinal Neurodegeneration Imaging and Cognitive Decline
Optical coherence tomography assessment of retinal nerve fiber layer thinning as neuroimaging biomarker for central neurodegeneration processes.
Explore frontiers →
Focal Cortical Dysplasia Surgery Outcomes and Seizure Recurrence
Population epidemiology of surgical outcomes, post-operative seizure freedom rates, and developmental outcome trajectories in focal cortical dysplasia.
Explore frontiers →
Essential Tremor Misclassification and Phenotype Refinement
Systematic reassessment of essential tremor diagnostic criteria and prevalence of mimicking conditions in population-based neurological surveys.
Explore frontiers →
Motor Neuron Disease Phenotypic Heterogeneity and Progression
Epidemiological characterization of amyotrophic lateral sclerosis phenotypes and survival prediction models incorporating clinical, genetic, and imaging features.
Explore frontiers →
Intracerebral Hemorrhage Outcome Prediction and Rehabilitation
Development of early clinical and neuroimaging hematoma expansion prediction models and long-term functional recovery epidemiology.
Explore frontiers →
Idiopathic Normal-Pressure Hydrocephalus Diagnostic Accuracy
Population-based assessment of diagnostic test performance and shunt-responsive criteria specificity in elderly populations with gait disturbance.
Explore frontiers →
Pediatric Ischemic Stroke Etiologic Classification Epidemiology
Systematic characterization of stroke etiology prevalence, prothrombotic risk factors, and recurrence rates in childhood arterial ischemic stroke populations.
Explore frontiers →
Posterior Reversible Encephalopathy Syndrome Risk Stratification
Epidemiological analysis of posterior reversible encephalopathy syndrome incidence, precipitating conditions, and long-term neurological complication rates.
Explore frontiers →
Friedreich Ataxia Natural History and Progression Markers
Longitudinal characterization of Friedreich ataxia disease progression, cardiac involvement epidemiology, and biomarker prediction of functional decline rates.
Explore frontiers →
Cavernous Malformation Hemorrhage Incidence and Risk Factors
Population-based natural history studies of cerebral cavernous malformation bleeding risk stratification and familial clustering patterns.
Explore frontiers →
Bacterial Meningitis Sequelae and Long-Term Outcomes Registry
Prospective tracking of hearing loss, cognitive impairment, and neurological disability prevalence in bacterial meningitis survivor populations.
Explore frontiers →
Neurosyphilis Resurgence and Screening Effectiveness
Epidemiological surveillance of neurosyphilis incidence, clinical presentation patterns, and diagnostic testing performance in vulnerable populations.
Explore frontiers →
Hemiplegic Migraine Genetic Epidemiology and Comorbidity
Family-based and population studies of CACNA1A, ATP1A2, and SCN1A mutation prevalence and associated neurological phenotypes.
Explore frontiers →
Vestibular Schwannoma Growth Rate Prediction and Management
Natural history epidemiology of acoustic neuromas characterizing growth patterns, hearing preservation outcomes, and optimal surveillance strategies.
Explore frontiers →
Dementia Reverse Causality and Reverse Translation Studies
Population-based mechanistic studies examining whether early disease processes cause apparent risk factor associations versus true etiologic pathways.
Explore frontiers →
Immune Checkpoint Inhibitor-Associated Neurotoxicity Epidemiology
Systematic characterization of immune-related adverse neurological events incidence and risk factors in cancer immunotherapy populations.
Explore frontiers →
Viral Vector Gene Therapy Safety and Immunogenicity
Post-market surveillance epidemiology of adverse events and immunological responses following approved neurological gene therapy interventions.
Explore frontiers →
Functional Movement Disorder Incidence and Psychological Risk
Population-based epidemiology of functional neurological symptom disorder with psychological trauma exposure and psychiatric comorbidity characterization.
Explore frontiers →
Aneurysmal Subarachnoid Hemorrhage Screening and Prevention
Risk stratification of unruptured intracranial aneurysm rupture probability and optimal screening strategies in high-risk populations.
Explore frontiers →
Lyme Disease Post-Treatment Lyme Disease Syndrome Epidemiology
Population characterization of persistent cognitive and neurological symptom prevalence following antibiotic-treated Lyme disease.
Explore frontiers →
Metachromatic Leukodystrophy Natural History and Treatment Response
Longitudinal characterization of metachromatic leukodystrophy phenotypes, disease progression rates, and treatment outcome trajectories.
Explore frontiers →
Subclinical Cerebrovascular Disease Burden and Outcomes
Epidemiological assessment of silent brain infarcts, white matter hyperintensities, and microinfarct burden predictive value for cognitive and motor outcomes.
Explore frontiers →
Restless Legs Syndrome Genetic Epidemiology and Iron Metabolism
Population studies of restless legs syndrome prevalence, genetic susceptibility loci, and iron homeostasis dysregulation in susceptible individuals.
Explore frontiers →
Neurological Birth Defect Surveillance and Prevention Programs
Active case surveillance of neural tube defects, holoprosencephaly, and hydrocephalus with maternal exposure and genetic risk factor investigation.
Explore frontiers →
Transient Ischemic Attack Recurrence Risk Stratification
Development of validated prediction models for stroke risk following transient ischemic attack with optimal intervention timing evaluation.
Explore frontiers →
Cognitive Reserve Neuroimaging Correlates and Mechanisms
Population neuroimaging studies identifying structural and functional brain characteristics underlying cognitive reserve resilience mechanisms.
Explore frontiers →
Neuromyelitis Optica Spectrum Disease Epidemiology and Classification
Population epidemiology of neuromyelitis optica spectrum disorders with aquaporin-4 and myelin oligodendrocyte glycoprotein antibody characterization.
Explore frontiers →
Diabetic Autonomic Neuropathy Cardiovascular Mortality Risk
Population studies of autonomic neuropathy prevalence and sudden cardiac death risk in diabetes populations with heart rate variability assessment.
Explore frontiers →
Neurotoxic Pesticide Exposure and Neurodegenerative Disease
Occupational and residential pesticide exposure assessment and association with amyotrophic lateral sclerosis and Parkinson''s disease incidence.
Explore frontiers →
Spontaneous Lobar Intracerebral Hemorrhage Mechanism Discovery
Epidemiological investigation of lobar intracerebral hemorrhage etiology including cerebral amyloid angiopathy, microhemorrhage burden, and genetic risk factors.
Explore frontiers →
Concussion Proteomic Biomarkers and Recovery Prediction
Population-based discovery of post-concussion cerebrospinal fluid and serum proteomic signatures predictive of post-concussion syndrome development.
Explore frontiers →
Guillain-Barré Syndrome Outcome Prediction and Rehabilitation
Population natural history of Guillain-Barré syndrome subtypes with prognostic factor identification and long-term disability trajectory characterization.
Explore frontiers →
Autoimmune Encephalitis Case Ascertainment and Outcomes
Systematic case finding and epidemiological characterization of autoimmune encephalitis subtypes with antigen-specific antibody prevalence assessment.
Explore frontiers →
Chronic Subdural Hematoma Risk Factors in Anticoagulated Patients
Population epidemiology of chronic subdural hematoma incidence and recurrence in anticoagulated populations with risk stratification models.
Explore frontiers →
Long COVID Neurological Sequelae Epidemiology
Investigation of persistent neurological complications following SARS-CoV-2 infection and their population-level incidence, severity, and recovery trajectories.
Explore frontiers →
Artificial Intelligence Diagnostic Accuracy Neuroepidemiology
Evaluation of machine learning algorithms for neurological disease classification and population screening using epidemiological datasets.
Explore frontiers →
Extreme Heat Exposure and Heat Stroke Epidemiology
Population-level assessment of environmental temperature extremes on acute neurological emergencies and long-term brain injury outcomes.
Explore frontiers →
Pfizer Moderna Myocarditis Neurological Comorbidity
Epidemiological surveillance of neurological manifestations and safety outcomes in vaccine-associated myocarditis populations.
Explore frontiers →
Frontotemporal Dementia Genetic Anticipation Patterns
Analysis of disease progression acceleration across generations in familial frontotemporal dementia populations and genotype-phenotype relationships.
Explore frontiers →
Neurological Disability Adjusted Life Years Methodology
Development and validation of standardized burden measurement techniques for quantifying neurological disease impact across populations.
Explore frontiers →
Telomere Length and Brain Aging Trajectories
Prospective investigation of cellular aging biomarkers as predictors of cognitive decline and neurodegeneration risk in aging cohorts.
Explore frontiers →
Lymphatic System Dysfunction and Neuroinflammation
Population studies of glymphatic system impairment and cerebral lymphatic clearance as pathogenic mechanisms in neurological disease.
Explore frontiers →
Wildfire Smoke Exposure and Acute Stroke Risk
Real-time epidemiological analysis of particulate matter from wildfires and acute neurological events in exposed populations.
Explore frontiers →
Monoclonal Antibody Therapy Neurological Adverse Events
Pharmacoepidemiology surveillance of neurological safety signals and adverse outcomes in populations receiving immunobiological treatments.
Explore frontiers →
Social Determinants and Stroke Mortality Disparities
Investigation of socioeconomic factors and structural inequities driving differential stroke outcomes across demographic populations.
Explore frontiers →
Neurotropic Arthropod-Borne Virus Surveillance
Population-based surveillance and risk modeling for emerging neurological complications from vector-borne pathogens.
Explore frontiers →
Autoimmune Encephalitis Epidemiological Characterization
Systematic investigation of incidence, clinical phenotypes, and immunological mechanisms of autoimmune brain inflammation in population cohorts.
Explore frontiers →
Reversible Cerebral Vasoconstriction Syndrome Triggers
Epidemiological identification of precipitating factors and risk populations for transient cerebral arterial dysfunction.
Explore frontiers →
Chemotherapy-Related Cognitive Impairment Long-Term
Longitudinal population tracking of cancer therapy neurotoxicity and persistent cognitive deficits across survivor cohorts.
Explore frontiers →
Chronic Subdural Hematoma Risk Stratification
Development of predictive models for recurrence and mortality in elderly populations with chronic intracranial bleeding.
Explore frontiers →
Neurological Outcomes in Extreme Altitude Populations
Investigation of hypoxia-related neurological adaptation, cerebral edema risk, and cognitive outcomes in high-altitude resident populations.
Explore frontiers →
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Epidemiological characterization of immune-mediated encephalitis with glutamate receptor antibodies and psychiatric-neurological manifestations.
Explore frontiers →
Neonatal Hypoxic-Ischemic Encephalopathy Outcomes
Population studies of birth asphyxia sequelae including cerebral palsy phenotypes and long-term neurodevelopmental trajectories.
Explore frontiers →
Neurological Disease Clustering in Urban Centers
Spatial epidemiological analysis of non-random geographic aggregation patterns for specific neurological conditions.
Explore frontiers →
Fragile X-Associated Tremor Ataxia Phenotypes
Investigation of FMR1 premutation expansion and clinical heterogeneity in late-onset neurological disorder populations.
Explore frontiers →
Neurological Complications in Inborn Errors Metabolism
Epidemiological assessment of inherited metabolic disease burden and preventable neurological outcomes with early intervention.
Explore frontiers →
Cervical Artery Dissection Risk Factor Identification
Case-control and cohort investigation of predisposing genetic and environmental factors in spontaneous vascular dissection.
Explore frontiers →
Prion Disease Surveillance and Variant Detection
Population-based monitoring of transmissible spongiform encephalopathy emergence and molecular strain characterization.
Explore frontiers →
Hemiplegic Migraine and Familial Genetic Burden
Investigation of CACNA1A and SCN1A mutations and genotype-phenotype correlations in familial hemiplegic migraine populations.
Explore frontiers →
Neurological Outcomes Following Bariatric Surgery
Prospective cohort analysis of metabolic and nutritional factors influencing cognitive and neurological complications post-surgery.
Explore frontiers →
Mitochondrial Disease Epidemiological Burden Assessment
Population prevalence estimation and disease progression tracking for nuclear and mitochondrial genetic neurological disorders.
Explore frontiers →
Stroke Prevention Intervention Effectiveness Comparison
Comparative effectiveness research evaluating population outcomes across various primary and secondary stroke prevention strategies.
Explore frontiers →
Neurological Manifestations Lyme Disease Spirochete
Epidemiological investigation of tick-borne Borrelia infection neurological sequelae and chronic post-treatment complications.
Explore frontiers →
Ischemic Stroke Thrombolytic Therapy Disparities
Analysis of demographic and geographic inequities in access to time-sensitive stroke interventions and outcomes.
Explore frontiers →
Restless Legs Syndrome Genetic Architecture Studies
Genome-wide association studies and pathway analysis identifying genetic variants predisposing to RLS in diverse populations.
Explore frontiers →
Intracranial Hypertension Idiopathic Epidemiology
Investigation of pseudotumor cerebri etiopathogenesis and burden particularly in reproductive-age female populations.
Explore frontiers →
Acute Disseminated Encephalomyelitis Post-Infection
Population surveillance of post-infectious demyelinating disease and comparison with vaccine-temporal associations.
Explore frontiers →
Tarlov Cysts and Neurological Symptom Causality
Epidemiological assessment of spinal nerve root cyst association with pain and neurological dysfunction in asymptomatic populations.
Explore frontiers →
Charcot-Marie-Tooth Disease Phenotypic Heterogeneity
Large-scale characterization of genotype-phenotype correlations and disease progression variability across CMT subtypes.
Explore frontiers →
Neurological Outcomes in Severe Malaria Infection
Population-level investigation of cerebral malaria sequelae including cognitive impairment and seizure outcomes.
Explore frontiers →
Cavernous Malformation Natural History Epidemiology
Large prospective cohort study of hemorrhage risk, seizure probability, and outcomes in familial cerebral cavernoma populations.
Explore frontiers →
Moyamoya Disease Geographic Incidence Variation
International epidemiological comparison of progressive cerebral vasculopathy incidence and outcomes across ethnic populations.
Explore frontiers →
Neurological Complications Type 1 Diabetes Youth
Population tracking of diabetic neuropathy, cognitive dysfunction, and stroke risk in pediatric and young adult diabetic cohorts.
Explore frontiers →
Skull Base Meningioma Epidemiological Risk Factors
Investigation of hormonal, genetic, and environmental exposures predisposing to intracranial meningioma development.
Explore frontiers →
Posterior Reversible Encephalopathy Syndrome Triggers
Epidemiological identification of acute precipitants and risk factors for hypertensive encephalopathy complications.
Explore frontiers →
Wernicke Korsakoff Syndrome Prevention Strategies
Population-level assessment of alcohol-related neurological disease prevention through thiamine supplementation and intervention.
Explore frontiers →
Neurological Disease Burden Informal Care Costs
Economic and social epidemiology of caregiver burden and indirect costs in populations with chronic neurological conditions.
Explore frontiers →
Acute Intermittent Porphyria Neurological Crisis
Population surveillance and risk stratification of acute neurovisceral attacks in rare porphyrin metabolism disorder cohorts.
Explore frontiers →
Neurological Outcomes Following Cardiac Arrest
Prognostic epidemiology of hypoxic-ischemic brain injury and functional recovery trajectories in cardiac arrest survivors.
Explore frontiers →
Hereditary Spastic Paraplegia Classification Epidemiology
Large-scale characterization of HSP genetic subtypes and clinical phenotype variation across international populations.
Explore frontiers →
Neurological Safety Emerging Psychotropic Medications
Pharmacoepidemiological surveillance of movement disorders and cognitive effects in psychiatric medication-treated populations.
Explore frontiers →
Brain Tumor Epidemiology Pediatric Populations
Investigation of childhood central nervous system malignancy incidence, long-term neurological outcomes, and survival disparities.
Explore frontiers →
Neurological Disability Employment Rate Trajectories
Population study of work-related outcomes and economic productivity impacts in neurologically disabled populations.
Explore frontiers →
Vertebral Artery Hypoplasia Stroke Risk Assessment
Epidemiological investigation of unilateral vertebral artery underdevelopment and posterior circulation stroke susceptibility.
Explore frontiers →
Long COVID Neurological Sequelae Population Cohorts
Population-based epidemiological investigation of persistent neurological complications following SARS-CoV-2 infection, including cognitive dysfunction, autonomic dysfunction, and neuropathic symptoms across diverse geographic and demographic cohorts.
Explore frontiers →